Calidi Biotherapeutics, Inc.
CLDI · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22 | -$29 | -$25 | -$11 |
| Dep. & Amort. | $2 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $5 | $0 | $1 |
| Change in WC | -$2 | -$6 | $4 | $1 |
| Other Non-Cash | -$0 | $2 | $8 | $1 |
| Operating Cash Flow | -$20 | -$27 | -$13 | -$8 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $190 | $0 |
| Other Inv. Act. | -$0 | $0 | -$190 | -$0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2 | $1 | $1 | $2 |
| Stock Issued | $18 | $3 | $11 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $25 | -$0 | $8 |
| Financing Cash Flow | $27 | $29 | $12 | $10 |
| Forex Effect | -$0 | -$0 | $1 | -$0 |
| Net Chg. in Cash | $8 | $2 | -$1 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2 | $1 | $1 | $0 |
| End Cash | $10 | $2 | $0 | $2 |
| Free Cash Flow | -$20 | -$28 | -$14 | -$8 |